Supplementary Figure 3 from Antitumor Effect of Farletuzumab Ecteribulin in Molecular Subtypes of Endometrial Cancer Patient-Derived Xenograft Models

Supplementary Figure 3 from Antitumor Effect of Farletuzumab Ecteribulin in Molecular Subtypes of Endometrial Cancer Patient-Derived Xenograft Models

<p>Supplementary Figure 3: The antitumor effect by FRa expression</p>

Enregistré dans:

Détails bibliographiques
Auteur principal:	Shigehiro Yagishita (15088446) (author)
Autres auteurs:	Sho Sato (15352614) (author), Daisuke Shintani (15352611) (author), Tadaaki Nishikawa (15033960) (author), Aiko Ogasawara (22547757) (author), Masanori Yasuda (15352623) (author), Hironori Ishii (22547760) (author), Keiji Furuuchi (20667857) (author), Toshimitsu Uenaka (20667860) (author), Hiroshi Yoshida (15044363) (author), Kosei Hasegawa (15352632) (author), Akinobu Hamada (15352635) (author)
Publié:	2025
Sujets:	Cancer Methods and Technology Gynecological Cancers Endometrial cancer Uterine cancer Imaging Imaging probes
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Soyez le premier à ajouter un commentaire!